Cronos Group Inc. (CRON.TO)
CAD 2.72
(-2.51%)
CAD 2.72
(-2.51%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -666.73 Million USD | 12.36% |
| 2022 | -760.76 Million USD | 13.27% |
| 2021 | -877.16 Million USD | 17.88% |
| 2020 | -1.06 Billion USD | 10.43% |
| 2019 | -1.19 Billion CAD | -13803.43% |
| 2018 | -8.57 Million CAD | -180.82% |
| 2017 | -3.05 Million CAD | -866.25% |
| 2016 | 398.62 Thousand CAD | 26.39% |
| 2015 | 315.38 Thousand CAD | 153.8% |
| 2014 | -586.22 Thousand CAD | -7943.76% |
| 2013 | -7288.00 CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -852.85 Million USD | -27.91% |
| 2024 Q2 | -846.19 Million USD | 0.78% |
| 2023 Q3 | -568.95 Million USD | -40.07% |
| 2023 FY | -666.73 Million USD | 12.36% |
| 2023 Q1 | -410.13 Million USD | 46.09% |
| 2023 Q2 | -406.2 Million USD | 0.96% |
| 2023 Q4 | -666.73 Million USD | -17.19% |
| 2022 Q3 | -626.4 Million USD | 19.76% |
| 2022 FY | -760.76 Million USD | 13.27% |
| 2022 Q1 | -852.26 Million USD | 2.84% |
| 2022 Q4 | -760.76 Million USD | -21.45% |
| 2022 Q2 | -780.62 Million USD | 8.41% |
| 2021 Q2 | -887.64 Million USD | 12.56% |
| 2021 FY | -877.16 Million USD | 17.88% |
| 2021 Q1 | -1.01 Billion USD | 4.97% |
| 2021 Q4 | -877.16 Million USD | -5.4% |
| 2021 Q3 | -832.26 Million USD | 6.24% |
| 2020 Q2 | -1.09 Billion USD | 1.64% |
| 2020 Q3 | -1.08 Billion USD | 1.05% |
| 2020 Q4 | -1.06 Billion USD | 1.82% |
| 2020 FY | -1.06 Billion USD | 10.43% |
| 2020 Q1 | -1.11 Billion USD | 6.26% |
| 2019 FY | -1.19 Billion CAD | -13803.43% |
| 2019 Q4 | -1.19 Billion CAD | -7.6% |
| 2019 Q3 | -1.1 Billion CAD | 7.65% |
| 2019 Q2 | -1.2 Billion CAD | 33.66% |
| 2019 Q1 | -1.8 Billion CAD | -20994.24% |
| 2018 Q4 | -8.57 Million CAD | 69.01% |
| 2018 Q1 | -20.73 Million CAD | -578.75% |
| 2018 FY | -8.57 Million CAD | -180.82% |
| 2018 Q3 | -27.67 Million CAD | 56.69% |
| 2018 Q2 | -63.9 Million CAD | -208.22% |
| 2017 Q3 | -8.58 Million CAD | -153.25% |
| 2017 Q2 | -3.38 Million CAD | 59.68% |
| 2017 FY | -3.05 Million CAD | -866.25% |
| 2017 Q1 | -8.4 Million CAD | -2208.07% |
| 2017 Q4 | -3.05 Million CAD | 64.4% |
| 2016 Q2 | -2.59 Million CAD | -370.31% |
| 2016 Q4 | 398.62 Thousand CAD | 129.45% |
| 2016 Q3 | -1.35 Million CAD | 47.88% |
| 2016 FY | 398.62 Thousand CAD | 26.39% |
| 2016 Q1 | 960.63 Thousand CAD | 204.59% |
| 2015 Q3 | 927.94 Thousand CAD | 157.08% |
| 2015 Q1 | 198.07 Thousand CAD | 0.0% |
| 2015 FY | 315.38 Thousand CAD | 153.8% |
| 2015 Q4 | 315.38 Thousand CAD | -66.01% |
| 2015 Q2 | 360.96 Thousand CAD | 82.24% |
| 2014 Q3 | -661.26 Thousand CAD | -217.3% |
| 2014 FY | -586.22 Thousand CAD | -7943.76% |
| 2014 Q2 | -208.4 Thousand CAD | 0.0% |
| 2013 FY | -7288.00 CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | -8.64 Million CAD | -7609.736% |
| Avicanna Inc. | 1.32 Million CAD | 50374.356% |
| Avant Brands Inc. | 17.93 Million CAD | 3818.561% |
| Cardiol Therapeutics Inc. | -34.77 Million CAD | -1817.388% |
| Crescita Therapeutics Inc. | -8.13 Million CAD | -8099.951% |
| Knight Therapeutics Inc. | 10.33 Million CAD | 6554.385% |
| MediPharm Labs Corp. | -15.68 Million CAD | -4150.529% |
| OrganiGram Holdings Inc. | -33.7 Million CAD | -1877.923% |
| Canopy Growth Corporation | 512.87 Million CAD | 230.001% |
| Willow Biosciences Inc. | -989 Thousand CAD | -67315.369% |
| Auxly Cannabis Group Inc. | 142.88 Million CAD | 566.642% |